Azenta Enhances Global Biorepository Services with UK Biocentre Acquisition Azenta's acquisition of UK Biocentre marks a significant enhancement in its biorepository capabilities, strengthening operations in Europe.

Azenta Enhances Global Biorepository Services with UK Biocentre Acquisition #Burlington #United_Kingdom #biorepository #UK_Biocentre #Azenta

Azenta to Showcase Innovations at Raymond James 47th Annual Institutional Investor Conference Azenta, Inc. will participate in the Raymond James 47th Annual Institutional Investor Conference with a presentation on March 3, 2026. Join to discover their latest life sciences solutions.

Azenta to Showcase Innovations at Raymond James 47th Annual Institutional Investor Conference #United_States #Burlington #investor_conference #Life_Sciences #Azenta

Azenta, Inc. Reports First Quarter Fiscal 2026 Financial Results Detailing Continued Operations and Strategic Sales Azenta, Inc. announces its financial results for Q1 2026, highlighting revenue performance and strategic plans for discontinued operations. The report emphasizes ongoing initiatives and future growth outlook.

Azenta, Inc. Reports First Quarter Fiscal 2026 Financial Results Detailing Continued Operations and Strategic Sales #USA #Burlington,_Massachusetts #Azenta #Fiscal_2026 #B_Medical_Systems

Azenta Announces the Sale of B Medical Systems to THELEMA S.À R.L. Azenta, Inc. has agreed to sell its B Medical Systems business for $63 million to THELEMA S.À R.L., aiming to streamline operations and focus on core strengths.

Azenta Announces the Sale of B Medical Systems to THELEMA S.À R.L. #United_States #Burlington #Azenta #B_Medical_Systems #THELEMA

Azenta Announces $250 Million Share Repurchase Initiative to Boost Shareholder Value Azenta, Inc. has authorized a significant share repurchase program aimed at enhancing shareholder value by buying back up to $250 million of its stock.

Azenta Announces $250 Million Share Repurchase Initiative to Boost Shareholder Value #United_States #share_repurchase #stock_buyback #Azenta #Burlington,_MA

Azenta, Inc. Reports Strong Fiscal 2025 Year-End Results with Notable Growth Azenta, Inc. showcased impressive financial performance for the fourth quarter and full fiscal year 2025, highlighting significant growth and margin improvements.

Azenta, Inc. Reports Strong Fiscal 2025 Year-End Results with Notable Growth #USA #Inc. #financial_results #Fiscal_2025 #Burlington,_Massachusetts #Azenta

Azenta Life Sciences Collaborates with PRECEDE Foundation for Pancreatic Cancer Early Detection Initiative Azenta Life Sciences has announced a partnership with PRECEDE Foundation aimed at enhancing early detection methods for pancreatic cancer, improving patient survival rates significantly.

Azenta Life Sciences Collaborates with PRECEDE Foundation for Pancreatic Cancer Early Detection Initiative #United_States #Burlington #pancreatic_cancer #Azenta #PRECEDE_Foundation

Azenta Announces Investor Day to Showcase Innovations at its Indianapolis Biorepository Join Azenta on December 10, 2025, for an exclusive Investor Day at its biorepository in Indianapolis, offering in-depth insights into its strategic innovations.

Azenta Announces Investor Day to Showcase Innovations at its Indianapolis Biorepository #United_States #Indianapolis #Investor_Day #biorepository #Azenta

Azenta Inc. Reports Q3 Fiscal Year 2025 Financial Results and Outlook Azenta, Inc. delivers its financial results for the third quarter of 2025 and reiterates guidance for the full fiscal year, showcasing ongoing operational improvements.

Azenta Inc. Reports Q3 Fiscal Year 2025 Financial Results and Outlook #United_States #Burlington #Azenta #B_Medical_Systems #Nasdaq_AZTA

Azenta to Showcase Innovations at Needham Virtual MedTech & Diagnostics Conference Azenta, Inc. announces its upcoming participation in the 10th Annual Needham Virtual MedTech & Diagnostics Conference, promoting life sciences innovations.

Azenta to Showcase Innovations at Needham Virtual MedTech & Diagnostics Conference #United_States #Burlington #MedTech #Life_Sciences #Azenta

Celebrating one year since #Azenta Life Sciences opened the doors to our #GENEWIZ #genomics lab in #Oxford, #UK!

We’re excited to share some highlights from the opening, featuring amazing UK customers and the leadership team who made it all happen, catch a glimpse: youtu.be/ThElHaktJOs?...

Azenta, Inc. Releases Financial Results for Second Quarter of Fiscal 2025 Ending March 31 Azenta, Inc. has disclosed its financial outcomes for the second quarter of fiscal 2025, highlighting a notable resilience in its operations amidst a challenging economic landscape.

Azenta, Inc. Releases Financial Results for Second Quarter of Fiscal 2025 Ending March 31 #USA #Burlington #Life_Sciences #Q2_2025 #Azenta

Azenta's 2024 ESG Report Highlights Commitment to Sustainability and Social Impact Azenta, Inc. unveils its 2024 Environmental, Social, and Governance report, showcasing advancements in sustainability and social initiatives.

Azenta's 2024 ESG Report Highlights Commitment to Sustainability and Social Impact #Sustainability #USA #Burlington #ESG_Report #Azenta

Azenta's Executive to Speak at KeyBanc Capital Markets Healthcare Forum Azenta, Inc. announces participation in the upcoming Virtual KeyBanc Capital Markets Healthcare Forum, featuring CFO Lawrence Y. Lin.

Azenta's Executive to Speak at KeyBanc Capital Markets Healthcare Forum #United_States #healthcare #Burlington #Azenta #KeyBanc

Azenta Inc. Reports Q1 2025 Financial Results and Positive Growth Trends Azenta, Inc. presents its financial results for Q1 2025 with notable growth in revenue, emphasizing successful market strategies and transformation efforts.

Azenta Inc. Reports Q1 2025 Financial Results and Positive Growth Trends #United_States #Burlington #Multiomics #Azenta #Sample_Management

Dipal Doshi Joins Azenta's Board of Directors as a Strategic Move Dipal Doshi, CEO of Entrada Therapeutics, has been elected to Azenta's Board of Directors, signaling a strategic enhancement for the firm.

Dipal Doshi Joins Azenta's Board of Directors as a Strategic Move #USA #Burlington #Azenta #Dipal_Doshi #Entrada_Therapeutics

UK Biocentre Partners with Azenta for Advanced Sample Storage Solutions in Research UK Biocentre has chosen Azenta's BioArc Ultra system to enhance sample storage capabilities, fostering impactful research and sustainability.

UK Biocentre Partners with Azenta for Advanced Sample Storage Solutions in Research #United_Kingdom #Milton_Keynes #BioArc_Ultra #UK_Biocentre #Azenta